REDDING, Calif. , July 8, 2024 /PRNewswire/ -- According to a new market research report titled, ' IVD Reagents Market Size, Share, Forecast, & Trends Analysis by Type (Antibodies, Proteins, Oligonucleotides, Nucleic Acid Probes) Technology (Immunoassay, Biochemistry, Microbiology, Hematology) Use (Clinical, RUO) End User - Global Forecast to 2031,' published by Meticulous Research ® , the IVD reagents market is projected to reach $79.76 billion by 2031 , at a CAGR of 5.
3% from 2024 to 2031. Download Sample Report Now- https://www.meticulousresearch.
com/download-sample-report/cp_id=5110 In-vitro diagnostic (IVD) reagents include oligonucleotides, antibodies, nucleic acid probes, purified proteins or peptides, buffers, calibrators, serum, cell medium, and standards & controls used in research activities. These reagents are used to diagnose and prevent diseases or other conditions and manufacture IVD kits & assays for diagnostic purposes. The growth of this market is driven by the increasing prevalence of infectious diseases, increasing funding for research activities, the rising adoption of advanced diagnostic technologies, the growth in proteomics and genomics research studies, and the growing number of clinical laboratories offering advanced diagnostic testing menus.
Additionally, emerging economies and the growing demand for protein therapeutics & personalized medicines are expected to offer significant market growth opportunities. However, the stringent regulations for an.